

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of interleukin-8 secretion (GO:2000484) | 9.92712023 |
| 2 | positive thymic T cell selection (GO:0045059) | 9.20349677 |
| 3 | negative thymic T cell selection (GO:0045060) | 8.73246974 |
| 4 | negative T cell selection (GO:0043383) | 8.64754882 |
| 5 | thymic T cell selection (GO:0045061) | 8.35822338 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.25666261 |
| 7 | positive T cell selection (GO:0043368) | 7.88738131 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.54905857 |
| 9 | T cell selection (GO:0045058) | 7.43204694 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.19527880 |
| 11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.02487903 |
| 12 | sequestering of actin monomers (GO:0042989) | 6.82604019 |
| 13 | T cell receptor signaling pathway (GO:0050852) | 6.44797558 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 6.40340649 |
| 15 | heterotypic cell-cell adhesion (GO:0034113) | 6.33579514 |
| 16 | T cell costimulation (GO:0031295) | 6.29732198 |
| 17 | lymphocyte costimulation (GO:0031294) | 6.17190267 |
| 18 | regulation of T cell tolerance induction (GO:0002664) | 6.09399971 |
| 19 | regulation of interleukin-8 secretion (GO:2000482) | 5.87523600 |
| 20 | membrane raft organization (GO:0031579) | 5.81954118 |
| 21 | negative regulation of cell killing (GO:0031342) | 5.68095248 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.68095248 |
| 23 | interferon-gamma production (GO:0032609) | 5.45744323 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44842388 |
| 25 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.41128927 |
| 26 | response to interleukin-15 (GO:0070672) | 5.37747618 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.36097512 |
| 28 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.28344677 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 5.25075096 |
| 30 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.12067251 |
| 31 | leukocyte aggregation (GO:0070486) | 5.09753505 |
| 32 | localization within membrane (GO:0051668) | 5.08617370 |
| 33 | cytolysis (GO:0019835) | 5.01203463 |
| 34 | positive regulation of tolerance induction (GO:0002645) | 4.97689433 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 4.86270704 |
| 36 | T cell migration (GO:0072678) | 4.77460490 |
| 37 | morphogenesis of an endothelium (GO:0003159) | 4.75104935 |
| 38 | endothelial tube morphogenesis (GO:0061154) | 4.75104935 |
| 39 | negative regulation of phagocytosis (GO:0050765) | 4.63055996 |
| 40 | positive regulation of humoral immune response (GO:0002922) | 4.62749120 |
| 41 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.62514609 |
| 42 | regulation of defense response to virus by virus (GO:0050690) | 4.61160748 |
| 43 | response to type I interferon (GO:0034340) | 4.61118253 |
| 44 | negative regulation of T cell apoptotic process (GO:0070233) | 4.59047712 |
| 45 | cellular response to type I interferon (GO:0071357) | 4.54787840 |
| 46 | type I interferon signaling pathway (GO:0060337) | 4.54787840 |
| 47 | natural killer cell activation (GO:0030101) | 4.53184876 |
| 48 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.37863141 |
| 49 | positive regulation of interferon-gamma production (GO:0032729) | 4.30607202 |
| 50 | regulation of tolerance induction (GO:0002643) | 4.28824915 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 4.26690133 |
| 52 | regulation of B cell differentiation (GO:0045577) | 4.26206677 |
| 53 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.25300228 |
| 54 | mast cell activation (GO:0045576) | 4.21666120 |
| 55 | cell wall macromolecule catabolic process (GO:0016998) | 4.18781762 |
| 56 | regulation of activation of Janus kinase activity (GO:0010533) | 4.16794524 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.15654025 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.10141706 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.10141706 |
| 60 | positive regulation of granulocyte differentiation (GO:0030854) | 4.09406710 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.06524394 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.03942136 |
| 63 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.03687544 |
| 64 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.01570153 |
| 65 | mast cell activation involved in immune response (GO:0002279) | 3.93553462 |
| 66 | mast cell degranulation (GO:0043303) | 3.93553462 |
| 67 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.91072110 |
| 68 | regulation of response to interferon-gamma (GO:0060330) | 3.87206666 |
| 69 | T cell activation (GO:0042110) | 3.80963175 |
| 70 | positive regulation of interleukin-4 production (GO:0032753) | 3.77468446 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.76424283 |
| 72 | cytokine biosynthetic process (GO:0042089) | 3.74816329 |
| 73 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.73669302 |
| 74 | positive regulation of interleukin-17 production (GO:0032740) | 3.69856438 |
| 75 | T cell differentiation (GO:0030217) | 3.67900599 |
| 76 | regulation of interferon-gamma production (GO:0032649) | 3.65814905 |
| 77 | negative regulation of B cell mediated immunity (GO:0002713) | 3.62690719 |
| 78 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.62690719 |
| 79 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.62166069 |
| 80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60537727 |
| 81 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.59803888 |
| 82 | regulation of interleukin-4 production (GO:0032673) | 3.59252359 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.57328242 |
| 84 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.56708945 |
| 85 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.56708945 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.55449574 |
| 87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49046396 |
| 88 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49046396 |
| 89 | cell wall macromolecule metabolic process (GO:0044036) | 3.47670622 |
| 90 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.47147831 |
| 91 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.45427950 |
| 92 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.45014825 |
| 93 | activated T cell proliferation (GO:0050798) | 3.42900691 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.37769456 |
| 95 | respiratory burst (GO:0045730) | 3.36312680 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35307612 |
| 97 | regulation of alpha-beta T cell activation (GO:0046634) | 3.34181403 |
| 98 | cellular defense response (GO:0006968) | 3.33843485 |
| 99 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30898387 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30348847 |
| 101 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27965839 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 3.27800663 |
| 103 | positive regulation of T cell activation (GO:0050870) | 3.27696874 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.26731676 |
| 105 | signal complex assembly (GO:0007172) | 3.21970672 |
| 106 | regulation of T cell activation (GO:0050863) | 3.21384532 |
| 107 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19611427 |
| 108 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.19195752 |
| 109 | T cell lineage commitment (GO:0002360) | 3.18960275 |
| 110 | tolerance induction (GO:0002507) | 3.18849546 |
| 111 | regulation of hypersensitivity (GO:0002883) | 3.18191906 |
| 112 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.17567816 |
| 113 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.17126215 |
| 114 | B cell mediated immunity (GO:0019724) | 3.16290309 |
| 115 | T cell homeostasis (GO:0043029) | 3.15557435 |
| 116 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.12885865 |
| 117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12762863 |
| 118 | regulation of interleukin-2 production (GO:0032663) | 3.10285792 |
| 119 | negative regulation of stress fiber assembly (GO:0051497) | 3.09879422 |
| 120 | positive regulation of cell killing (GO:0031343) | 3.09469825 |
| 121 | cellular response to interleukin-4 (GO:0071353) | 3.09393927 |
| 122 | NIK/NF-kappaB signaling (GO:0038061) | 3.08310103 |
| 123 | megakaryocyte development (GO:0035855) | 3.07602425 |
| 124 | positive regulation of lamellipodium assembly (GO:0010592) | 3.06617443 |
| 125 | regulation of cell killing (GO:0031341) | 3.02859677 |
| 126 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.99555802 |
| 127 | regulation of T cell apoptotic process (GO:0070232) | 2.98477338 |
| 128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.98428537 |
| 129 | cellular extravasation (GO:0045123) | 2.97561137 |
| 130 | lymphocyte migration (GO:0072676) | 2.97176213 |
| 131 | alpha-beta T cell differentiation (GO:0046632) | 2.96828065 |
| 132 | positive regulation of lymphocyte activation (GO:0051251) | 2.96587401 |
| 133 | dendritic cell chemotaxis (GO:0002407) | 2.95239139 |
| 134 | negative regulation of type 2 immune response (GO:0002829) | 2.91102883 |
| 135 | mannose metabolic process (GO:0006013) | 2.89167440 |
| 136 | T-helper cell differentiation (GO:0042093) | 2.87949554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.39086351 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.36067494 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.53715869 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65573942 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.54892130 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.04121444 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.87629622 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.80006829 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.59123231 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 3.41258789 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.41034178 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.25647525 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20915289 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 3.09426167 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.98179748 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.74738064 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71294278 |
| 18 | MAF_26560356_Chip-Seq_TH2_Human | 2.42620454 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30436159 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29748581 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.25547322 |
| 22 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.16698231 |
| 23 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.01681839 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99464780 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.96703204 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82203989 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82116799 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80864664 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.78967949 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77019710 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70502101 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68457767 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64595165 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60881211 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59068876 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56465307 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53876970 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52853278 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49647453 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46711252 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46603715 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44653668 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42734875 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41758875 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.40494183 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40349559 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38491984 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38431637 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36556036 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36544826 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35291241 |
| 52 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.33190949 |
| 53 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32158514 |
| 54 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.29318236 |
| 55 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.29318236 |
| 56 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.29318236 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21015550 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.19464782 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19025372 |
| 60 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.17405060 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15618876 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15515909 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13136366 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12670749 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11351403 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09946583 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09563205 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05102873 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03238080 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03041492 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01769581 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99257942 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98758079 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95227626 |
| 75 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94390595 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94380665 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89976350 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89556309 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89025872 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88808081 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88662431 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88624994 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88332339 |
| 84 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88160811 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86887891 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85907398 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85846602 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85312659 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84939169 |
| 90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83190763 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82554735 |
| 92 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.82394913 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82023117 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77354050 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76532055 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74960654 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73897124 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73413519 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72813960 |
| 100 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72257859 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70707609 |
| 102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70034200 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68989794 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.68684892 |
| 105 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68565840 |
| 106 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.67107553 |
| 107 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66979146 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 0.66841692 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.66692299 |
| 110 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66605616 |
| 111 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.66485430 |
| 112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.66007239 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65572568 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64522474 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62527198 |
| 116 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.61609772 |
| 117 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.60183262 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.59168257 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58874167 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.58765364 |
| 121 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58397166 |
| 122 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.57673959 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.56744008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.95114263 |
| 2 | MP0002166_altered_tumor_susceptibility | 4.71165384 |
| 3 | MP0005671_abnormal_response_to | 4.70755957 |
| 4 | MP0002006_tumorigenesis | 3.63678463 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.60318505 |
| 6 | MP0000685_abnormal_immune_system | 3.54153752 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.95129501 |
| 8 | MP0001790_abnormal_immune_system | 2.91853466 |
| 9 | MP0005387_immune_system_phenotype | 2.91853466 |
| 10 | MP0009785_altered_susceptibility_to | 2.87902092 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.84766779 |
| 12 | MP0001800_abnormal_humoral_immune | 2.78457896 |
| 13 | MP0006082_CNS_inflammation | 2.73108205 |
| 14 | MP0002723_abnormal_immune_serum | 2.63292575 |
| 15 | MP0002398_abnormal_bone_marrow | 2.58172301 |
| 16 | MP0000703_abnormal_thymus_morphology | 2.57953707 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.56898469 |
| 18 | MP0001819_abnormal_immune_cell | 2.53260859 |
| 19 | MP0003724_increased_susceptibility_to | 2.51811550 |
| 20 | MP0001873_stomach_inflammation | 2.41136514 |
| 21 | MP0005025_abnormal_response_to | 2.40140893 |
| 22 | MP0004510_myositis | 2.37339114 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.36478499 |
| 24 | MP0003866_abnormal_defecation | 2.32554785 |
| 25 | MP0002405_respiratory_system_inflammati | 2.29250648 |
| 26 | MP0000716_abnormal_immune_system | 2.28859896 |
| 27 | MP0002009_preneoplasia | 2.27640188 |
| 28 | MP0003436_decreased_susceptibility_to | 2.22216399 |
| 29 | MP0002722_abnormal_immune_system | 2.16124859 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.14603165 |
| 31 | MP0005310_abnormal_salivary_gland | 2.10730731 |
| 32 | MP0004381_abnormal_hair_follicle | 2.09988740 |
| 33 | MP0003300_gastrointestinal_ulcer | 2.05434970 |
| 34 | MP0002933_joint_inflammation | 1.98064838 |
| 35 | MP0002822_catalepsy | 1.95049732 |
| 36 | MP0003303_peritoneal_inflammation | 1.94150858 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.93804397 |
| 38 | MP0004947_skin_inflammation | 1.80836887 |
| 39 | MP0002429_abnormal_blood_cell | 1.76366203 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.73634828 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.71826076 |
| 42 | MP0002163_abnormal_gland_morphology | 1.71203378 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.57398924 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.56130770 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.52975179 |
| 46 | MP0002419_abnormal_innate_immunity | 1.50041808 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.34189991 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.31611088 |
| 49 | MP0008260_abnormal_autophagy | 1.30248418 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.27245936 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.26671290 |
| 52 | MP0005670_abnormal_white_adipose | 1.18704034 |
| 53 | MP0001851_eye_inflammation | 1.18050056 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 1.14135794 |
| 55 | MP0001661_extended_life_span | 1.13966626 |
| 56 | MP0003045_fibrosis | 1.10908760 |
| 57 | MP0008469_abnormal_protein_level | 1.07358990 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 0.99360699 |
| 59 | MP0001853_heart_inflammation | 0.98822645 |
| 60 | MP0008961_abnormal_basal_metabolism | 0.95369286 |
| 61 | MP0001533_abnormal_skeleton_physiology | 0.91605522 |
| 62 | MP0002132_abnormal_respiratory_system | 0.86913683 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 0.83183467 |
| 64 | MP0002638_abnormal_pupillary_reflex | 0.82152217 |
| 65 | MP0003787_abnormal_imprinting | 0.78393567 |
| 66 | MP0004130_abnormal_muscle_cell | 0.75876973 |
| 67 | MP0003690_abnormal_glial_cell | 0.74906201 |
| 68 | MP0000858_altered_metastatic_potential | 0.74189706 |
| 69 | MP0005423_abnormal_somatic_nervous | 0.73081695 |
| 70 | MP0001663_abnormal_digestive_system | 0.70821179 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.70277410 |
| 72 | MP0000920_abnormal_myelination | 0.68657850 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 0.68484574 |
| 74 | MP0008569_lethality_at_weaning | 0.68383949 |
| 75 | MP0000490_abnormal_crypts_of | 0.66786072 |
| 76 | MP0000609_abnormal_liver_physiology | 0.65445148 |
| 77 | MP0003448_altered_tumor_morphology | 0.65161897 |
| 78 | MP0009840_abnormal_foam_cell | 0.64300866 |
| 79 | MP0004142_abnormal_muscle_tone | 0.63503546 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.61823674 |
| 81 | MP0005166_decreased_susceptibility_to | 0.60984035 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.60889554 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.60242345 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.58124202 |
| 85 | MP0003878_abnormal_ear_physiology | 0.55904983 |
| 86 | MP0005377_hearing/vestibular/ear_phenot | 0.55904983 |
| 87 | MP0004883_abnormal_blood_vessel | 0.54578933 |
| 88 | MP0003879_abnormal_hair_cell | 0.54116443 |
| 89 | MP0004742_abnormal_vestibular_system | 0.54006588 |
| 90 | MP0009763_increased_sensitivity_to | 0.53602365 |
| 91 | MP0001764_abnormal_homeostasis | 0.53586007 |
| 92 | MP0005535_abnormal_body_temperature | 0.50923954 |
| 93 | MP0000249_abnormal_blood_vessel | 0.50882006 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.50751458 |
| 95 | MP0003011_delayed_dark_adaptation | 0.48891462 |
| 96 | MP0003221_abnormal_cardiomyocyte_apopto | 0.48255900 |
| 97 | MP0000604_amyloidosis | 0.46480044 |
| 98 | MP0001542_abnormal_bone_strength | 0.44668529 |
| 99 | MP0005023_abnormal_wound_healing | 0.44156140 |
| 100 | MP0005390_skeleton_phenotype | 0.43885269 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.43656191 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.43408409 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.43151678 |
| 104 | MP0003795_abnormal_bone_structure | 0.43115329 |
| 105 | MP0009115_abnormal_fat_cell | 0.42807510 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.41925191 |
| 107 | MP0008872_abnormal_physiological_respon | 0.41518824 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.41279754 |
| 109 | MP0008873_increased_physiological_sensi | 0.39891624 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.39782245 |
| 111 | MP0005334_abnormal_fat_pad | 0.39131667 |
| 112 | MP0003091_abnormal_cell_migration | 0.38652767 |
| 113 | MP0001191_abnormal_skin_condition | 0.38271143 |
| 114 | MP0009697_abnormal_copulation | 0.37958266 |
| 115 | MP0002083_premature_death | 0.34651968 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.34461764 |
| 117 | MP0000613_abnormal_salivary_gland | 0.33436389 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.33262967 |
| 119 | MP0008874_decreased_physiological_sensi | 0.33227679 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.32922762 |
| 121 | MP0001243_abnormal_dermal_layer | 0.32915502 |
| 122 | MP0009764_decreased_sensitivity_to | 0.32856347 |
| 123 | MP0005165_increased_susceptibility_to | 0.28806842 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.28036181 |
| 125 | MP0008995_early_reproductive_senescence | 0.27000361 |
| 126 | MP0000598_abnormal_liver_morphology | 0.25942974 |
| 127 | MP0002168_other_aberrant_phenotype | 0.25444036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 9.00947380 |
| 2 | Abnormality of T cell number (HP:0011839) | 8.76413192 |
| 3 | Increased IgM level (HP:0003496) | 8.60640515 |
| 4 | Aplastic anemia (HP:0001915) | 6.61448638 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.34877941 |
| 6 | Abnormality of T cells (HP:0002843) | 5.65194946 |
| 7 | Stomatitis (HP:0010280) | 5.18691815 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 4.89823943 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 4.89778225 |
| 10 | Abnormality of macrophages (HP:0004311) | 4.85568699 |
| 11 | IgG deficiency (HP:0004315) | 4.84239765 |
| 12 | Lymphopenia (HP:0001888) | 4.79538622 |
| 13 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.61924097 |
| 14 | Combined immunodeficiency (HP:0005387) | 4.58512698 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.47676304 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.47676304 |
| 17 | Recurrent bronchitis (HP:0002837) | 4.34772156 |
| 18 | Abnormality of eosinophils (HP:0001879) | 4.27323261 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 4.22214927 |
| 20 | Optic neuritis (HP:0100653) | 4.22214927 |
| 21 | Eosinophilia (HP:0001880) | 4.15581663 |
| 22 | Recurrent viral infections (HP:0004429) | 4.11163041 |
| 23 | Recurrent fungal infections (HP:0002841) | 4.01229658 |
| 24 | Abnormality of the nasal mucosa (HP:0000433) | 4.00168676 |
| 25 | Joint swelling (HP:0001386) | 3.98406304 |
| 26 | Hypergammaglobulinemia (HP:0010702) | 3.93764107 |
| 27 | Nasal polyposis (HP:0100582) | 3.88380593 |
| 28 | Leukocytosis (HP:0001974) | 3.83342856 |
| 29 | Gingival bleeding (HP:0000225) | 3.63740113 |
| 30 | Recurrent otitis media (HP:0000403) | 3.54143789 |
| 31 | Chronic diarrhea (HP:0002028) | 3.45485405 |
| 32 | Granulocytopenia (HP:0001913) | 3.39052445 |
| 33 | IgM deficiency (HP:0002850) | 3.30108165 |
| 34 | Spontaneous hematomas (HP:0007420) | 3.26574612 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 3.26447937 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.19803355 |
| 37 | Colitis (HP:0002583) | 3.18291069 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 3.10081090 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.09194484 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.06849124 |
| 41 | Panhypogammaglobulinemia (HP:0003139) | 3.05668616 |
| 42 | Bronchitis (HP:0012387) | 3.03691620 |
| 43 | Recurrent abscess formation (HP:0002722) | 3.02697127 |
| 44 | Vasculitis (HP:0002633) | 2.92048355 |
| 45 | Hypoproteinemia (HP:0003075) | 2.91758809 |
| 46 | Increased IgE level (HP:0003212) | 2.89890730 |
| 47 | Thyroiditis (HP:0100646) | 2.88054421 |
| 48 | Periorbital edema (HP:0100539) | 2.84275649 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.83812043 |
| 50 | Hemiplegia (HP:0002301) | 2.83725795 |
| 51 | Epistaxis (HP:0000421) | 2.79847166 |
| 52 | Acute hepatic failure (HP:0006554) | 2.79127032 |
| 53 | Amyotrophic lateral sclerosis (HP:0007354) | 2.79112371 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.76055332 |
| 55 | Facial edema (HP:0000282) | 2.73479701 |
| 56 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.73404039 |
| 57 | Lymphoma (HP:0002665) | 2.70287179 |
| 58 | Pustule (HP:0200039) | 2.69461992 |
| 59 | Chronic otitis media (HP:0000389) | 2.60562488 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.59202668 |
| 61 | B lymphocytopenia (HP:0010976) | 2.59202668 |
| 62 | Abnormality of T cell physiology (HP:0011840) | 2.50776739 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.50130756 |
| 64 | Myositis (HP:0100614) | 2.49411522 |
| 65 | Entropion (HP:0000621) | 2.48812814 |
| 66 | IgA deficiency (HP:0002720) | 2.42736615 |
| 67 | Cheilitis (HP:0100825) | 2.38425109 |
| 68 | Hemoptysis (HP:0002105) | 2.37447840 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.37062627 |
| 70 | Large eyes (HP:0001090) | 2.35721836 |
| 71 | Hypochromic anemia (HP:0001931) | 2.35275425 |
| 72 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.33450608 |
| 73 | Global brain atrophy (HP:0002283) | 2.33356066 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.28925716 |
| 75 | Prolonged bleeding time (HP:0003010) | 2.27444219 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.26189757 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.26003176 |
| 78 | Anorexia (HP:0002039) | 2.25588388 |
| 79 | Abnormality of the columella (HP:0009929) | 2.25472470 |
| 80 | Recurrent skin infections (HP:0001581) | 2.19690057 |
| 81 | Prominent nose (HP:0000448) | 2.19024422 |
| 82 | Viral hepatitis (HP:0006562) | 2.18201706 |
| 83 | Poikiloderma (HP:0001029) | 2.17734270 |
| 84 | Pulmonary embolism (HP:0002204) | 2.15170286 |
| 85 | Microcytic anemia (HP:0001935) | 2.14929161 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11982141 |
| 87 | Petechiae (HP:0000967) | 2.10308899 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.09637542 |
| 89 | Villous atrophy (HP:0011473) | 2.09563213 |
| 90 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09563213 |
| 91 | Oral leukoplakia (HP:0002745) | 2.07284249 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 2.07003027 |
| 93 | Prostate neoplasm (HP:0100787) | 2.04274407 |
| 94 | Purpura (HP:0000979) | 2.03913318 |
| 95 | Recurrent sinusitis (HP:0011108) | 2.01491309 |
| 96 | Urticaria (HP:0001025) | 2.00949476 |
| 97 | Agammaglobulinemia (HP:0004432) | 1.99799980 |
| 98 | Bronchiectasis (HP:0002110) | 1.97157415 |
| 99 | Increased CSF protein (HP:0002922) | 1.96227842 |
| 100 | Microvesicular hepatic steatosis (HP:0001414) | 1.93725710 |
| 101 | Pancytopenia (HP:0001876) | 1.92830252 |
| 102 | Meningitis (HP:0001287) | 1.91994390 |
| 103 | Gangrene (HP:0100758) | 1.91518779 |
| 104 | Recurrent lower respiratory tract infections (HP:0002783) | 1.90934645 |
| 105 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88286923 |
| 106 | Keratitis (HP:0000491) | 1.86937745 |
| 107 | Palpebral edema (HP:0100540) | 1.85634579 |
| 108 | Basal cell carcinoma (HP:0002671) | 1.84105911 |
| 109 | Progressive inability to walk (HP:0002505) | 1.83255205 |
| 110 | Hypertriglyceridemia (HP:0002155) | 1.81176884 |
| 111 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.79265027 |
| 112 | Urinary urgency (HP:0000012) | 1.78425544 |
| 113 | Chest pain (HP:0100749) | 1.77387109 |
| 114 | Gastrointestinal inflammation (HP:0004386) | 1.77359842 |
| 115 | Encephalitis (HP:0002383) | 1.76777310 |
| 116 | Glomerulopathy (HP:0100820) | 1.75758508 |
| 117 | Abnormality of the pleura (HP:0002103) | 1.75082189 |
| 118 | Prominent metopic ridge (HP:0005487) | 1.74752488 |
| 119 | Frequent falls (HP:0002359) | 1.74618826 |
| 120 | Cutis marmorata (HP:0000965) | 1.73606539 |
| 121 | Polyneuropathy (HP:0001271) | 1.73342067 |
| 122 | Obstructive lung disease (HP:0006536) | 1.69844799 |
| 123 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69844799 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.69834458 |
| 125 | Gingivitis (HP:0000230) | 1.68127857 |
| 126 | Arterial thrombosis (HP:0004420) | 1.67013432 |
| 127 | Hepatitis (HP:0012115) | 1.66581068 |
| 128 | Anhidrosis (HP:0000970) | 1.63924784 |
| 129 | Skin ulcer (HP:0200042) | 1.57820910 |
| 130 | Thrombocytosis (HP:0001894) | 1.56990498 |
| 131 | Orchitis (HP:0100796) | 1.55193431 |
| 132 | Thyroid-stimulating hormone excess (HP:0002925) | 1.54571160 |
| 133 | Abnormal platelet volume (HP:0011876) | 1.54499031 |
| 134 | Abnormality of DNA repair (HP:0003254) | 1.53552211 |
| 135 | Increased density of long bones (HP:0006392) | 1.52652935 |
| 136 | Basal ganglia calcification (HP:0002135) | 1.52593133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.29993762 |
| 2 | MAP4K1 | 4.56765068 |
| 3 | FGFR4 | 3.85079391 |
| 4 | ZAP70 | 3.71996095 |
| 5 | IKBKE | 3.57681978 |
| 6 | TESK2 | 3.24053237 |
| 7 | ITK | 3.15915342 |
| 8 | TYK2 | 3.05111594 |
| 9 | JAK3 | 3.00295298 |
| 10 | LCK | 2.32968574 |
| 11 | FGFR3 | 2.26685589 |
| 12 | NLK | 2.23599634 |
| 13 | GRK6 | 2.11140596 |
| 14 | RIPK4 | 2.10338589 |
| 15 | CSK | 2.03375079 |
| 16 | STK10 | 1.94063908 |
| 17 | TBK1 | 1.71621605 |
| 18 | KDR | 1.67878405 |
| 19 | JAK1 | 1.67252631 |
| 20 | HCK | 1.65778894 |
| 21 | KIT | 1.64057151 |
| 22 | BTK | 1.62207816 |
| 23 | IRAK4 | 1.59861271 |
| 24 | DYRK1B | 1.57106749 |
| 25 | SYK | 1.56057413 |
| 26 | TEC | 1.52904656 |
| 27 | MAP3K14 | 1.52288608 |
| 28 | UHMK1 | 1.50927287 |
| 29 | MAPKAPK3 | 1.41079529 |
| 30 | PRKCH | 1.35903065 |
| 31 | BLK | 1.30769898 |
| 32 | PDK4 | 1.30348065 |
| 33 | PDK3 | 1.30348065 |
| 34 | GRK7 | 1.25059450 |
| 35 | SCYL2 | 1.19875964 |
| 36 | ERN1 | 1.19072106 |
| 37 | TESK1 | 1.18249844 |
| 38 | EIF2AK3 | 1.11723100 |
| 39 | FES | 1.11412968 |
| 40 | NME2 | 1.10066895 |
| 41 | CAMKK2 | 1.09192098 |
| 42 | YES1 | 1.08947994 |
| 43 | PRKCQ | 1.07437779 |
| 44 | CDK6 | 1.05457870 |
| 45 | HIPK2 | 1.02146568 |
| 46 | PDGFRB | 0.95113738 |
| 47 | TNK2 | 0.94644450 |
| 48 | INSR | 0.94556769 |
| 49 | ALK | 0.89861863 |
| 50 | IKBKB | 0.88832199 |
| 51 | TAOK1 | 0.88104090 |
| 52 | FYN | 0.88092734 |
| 53 | BRD4 | 0.85893020 |
| 54 | LYN | 0.83790427 |
| 55 | JAK2 | 0.83196362 |
| 56 | MARK2 | 0.81707139 |
| 57 | SMG1 | 0.80496242 |
| 58 | PTK2 | 0.80405241 |
| 59 | PTK6 | 0.76929203 |
| 60 | DAPK1 | 0.76658561 |
| 61 | CDK19 | 0.75884810 |
| 62 | FGFR2 | 0.75489166 |
| 63 | SIK2 | 0.73284235 |
| 64 | EEF2K | 0.71646544 |
| 65 | MAP2K6 | 0.71297598 |
| 66 | MARK3 | 0.71117505 |
| 67 | OXSR1 | 0.68075081 |
| 68 | TYRO3 | 0.67313733 |
| 69 | CHUK | 0.64711720 |
| 70 | IGF1R | 0.61658167 |
| 71 | PINK1 | 0.60446211 |
| 72 | PDK2 | 0.59951557 |
| 73 | CAMKK1 | 0.59234976 |
| 74 | MAP3K12 | 0.57960344 |
| 75 | CDK4 | 0.57756388 |
| 76 | LIMK1 | 0.55240177 |
| 77 | MAP3K13 | 0.54734620 |
| 78 | EPHB1 | 0.54050054 |
| 79 | MAP3K7 | 0.52511592 |
| 80 | STK24 | 0.52303768 |
| 81 | FGFR1 | 0.51729490 |
| 82 | PTK2B | 0.51541346 |
| 83 | CDK12 | 0.51219794 |
| 84 | CDK9 | 0.50943877 |
| 85 | ROCK2 | 0.48043107 |
| 86 | MAPK11 | 0.46948322 |
| 87 | LRRK2 | 0.45132767 |
| 88 | TAF1 | 0.45033873 |
| 89 | SRC | 0.44598077 |
| 90 | STK4 | 0.44585035 |
| 91 | ABL1 | 0.44311966 |
| 92 | SIK3 | 0.43680934 |
| 93 | MAPKAPK2 | 0.43384941 |
| 94 | TNIK | 0.42041820 |
| 95 | CLK1 | 0.40468184 |
| 96 | TLK1 | 0.38770168 |
| 97 | ADRBK2 | 0.37704505 |
| 98 | ILK | 0.37322241 |
| 99 | PASK | 0.35955098 |
| 100 | MAPK3 | 0.35166739 |
| 101 | TSSK6 | 0.34675975 |
| 102 | ERBB2 | 0.34230401 |
| 103 | MAP3K3 | 0.34216064 |
| 104 | PDK1 | 0.33799559 |
| 105 | PIM1 | 0.33291970 |
| 106 | MAP3K1 | 0.32300785 |
| 107 | MST4 | 0.31644744 |
| 108 | MAP3K11 | 0.31182064 |
| 109 | MOS | 0.30910442 |
| 110 | RPS6KL1 | 0.29401250 |
| 111 | RPS6KC1 | 0.29401250 |
| 112 | CDK3 | 0.28691810 |
| 113 | TTN | 0.28561162 |
| 114 | GRK5 | 0.28370065 |
| 115 | PRPF4B | 0.28334613 |
| 116 | PRKCB | 0.28224888 |
| 117 | CSF1R | 0.27054228 |
| 118 | MELK | 0.26781194 |
| 119 | NTRK2 | 0.26245968 |
| 120 | TAOK2 | 0.25631344 |
| 121 | EGFR | 0.25236504 |
| 122 | MAPK8 | 0.24823836 |
| 123 | PKN2 | 0.24636309 |
| 124 | NEK6 | 0.24572429 |
| 125 | MAPK7 | 0.24506197 |
| 126 | MAP3K10 | 0.23317597 |
| 127 | PRKD1 | 0.21535912 |
| 128 | TAOK3 | 0.20914724 |
| 129 | TGFBR2 | 0.20710224 |
| 130 | EPHA3 | 0.20558838 |
| 131 | CSNK1D | 0.19628945 |
| 132 | MAP2K3 | 0.19189321 |
| 133 | STK11 | 0.17897882 |
| 134 | CSNK1G1 | 0.17659141 |
| 135 | CSNK2A2 | 0.17490214 |
| 136 | FGR | 0.16548530 |
| 137 | PAK6 | 0.16401268 |
| 138 | MKNK2 | 0.16273241 |
| 139 | STK39 | 0.16242224 |
| 140 | PRKD2 | 0.15634180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.02342209 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.71553284 |
| 3 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.84420801 |
| 4 | Measles_Homo sapiens_hsa05162 | 3.56752662 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.26006360 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.16171908 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.73083329 |
| 8 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.55397322 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25151562 |
| 10 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.19820696 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05429559 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 2.03775904 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.01724242 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.97964270 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.95622265 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90451143 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86025283 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78348079 |
| 19 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58679027 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56686195 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50427072 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48370443 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43412999 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41872248 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41297550 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.24012412 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21968408 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.18986564 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.18812963 |
| 30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18717129 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18649430 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12516220 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12129042 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.06159929 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05203555 |
| 36 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04895793 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04276212 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98230849 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 0.95114769 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 0.93003232 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 0.91761439 |
| 42 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91463705 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90172409 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88750192 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.88270961 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.87418053 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82471838 |
| 48 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81552677 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81294826 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81107412 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.79128906 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77481840 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74227110 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74059702 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63847010 |
| 56 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63318949 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.62526891 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62362176 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62303577 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60029107 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58485654 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.58327136 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.57100459 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.56117225 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54610032 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53789804 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53648427 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49814708 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48530704 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.48488949 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48281612 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46691135 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45983094 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45399019 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43429138 |
| 76 | Asthma_Homo sapiens_hsa05310 | 0.43106399 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38331499 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38242722 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.38080851 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.37958784 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35917767 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.35692344 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35317724 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34898074 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33051131 |
| 86 | Apoptosis_Homo sapiens_hsa04210 | 0.32047206 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32033207 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30961128 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.30177241 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29241920 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28930552 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28644126 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26178549 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25640338 |
| 95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25292826 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25094992 |
| 97 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25049670 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23421655 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23241290 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21934331 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20490249 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17998821 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17051127 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16525904 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.15070738 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14893877 |
| 107 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14147652 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13491224 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13467998 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.13057646 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.12667736 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.11161776 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10924229 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.10714632 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.10674065 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.09325207 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09288349 |
| 118 | RNA transport_Homo sapiens_hsa03013 | 0.08361632 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.07574675 |
| 120 | Proteasome_Homo sapiens_hsa03050 | 0.06794130 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.05546319 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05021709 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.04932265 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.04769080 |

